MA46563A - Compositions dispersibles - Google Patents

Compositions dispersibles

Info

Publication number
MA46563A
MA46563A MA046563A MA46563A MA46563A MA 46563 A MA46563 A MA 46563A MA 046563 A MA046563 A MA 046563A MA 46563 A MA46563 A MA 46563A MA 46563 A MA46563 A MA 46563A
Authority
MA
Morocco
Prior art keywords
dispersible compositions
dispersible
compositions
Prior art date
Application number
MA046563A
Other languages
English (en)
Other versions
MA46563B1 (fr
Inventor
Nicolaas Martha Felix Goyvaerts
Harshad Patankar
Rajan Gopal Rajan Ranga
Original Assignee
Janssen Sciences Ireland Unlimited Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland Unlimited Co filed Critical Janssen Sciences Ireland Unlimited Co
Publication of MA46563A publication Critical patent/MA46563A/fr
Publication of MA46563B1 publication Critical patent/MA46563B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Furan Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
MA46563A 2016-10-24 2017-10-23 Compositions dispersibles MA46563B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201621036404 2016-10-24
PCT/EP2017/077030 WO2018077815A1 (fr) 2016-10-24 2017-10-23 Compositions dispersibles

Publications (2)

Publication Number Publication Date
MA46563A true MA46563A (fr) 2019-08-28
MA46563B1 MA46563B1 (fr) 2024-01-31

Family

ID=60262899

Family Applications (1)

Application Number Title Priority Date Filing Date
MA46563A MA46563B1 (fr) 2016-10-24 2017-10-23 Compositions dispersibles

Country Status (22)

Country Link
US (2) US11065198B2 (fr)
EP (2) EP3528791B1 (fr)
JP (2) JP7197474B2 (fr)
KR (2) KR20190073450A (fr)
CN (1) CN110191704A (fr)
BR (1) BR112019007564A2 (fr)
CA (1) CA3039562A1 (fr)
DK (1) DK3528791T3 (fr)
ES (1) ES2970870T3 (fr)
FI (1) FI3528791T3 (fr)
HR (1) HRP20240118T1 (fr)
HU (1) HUE064823T2 (fr)
LT (1) LT3528791T (fr)
MA (1) MA46563B1 (fr)
MX (1) MX2019004767A (fr)
PL (1) PL3528791T3 (fr)
PT (1) PT3528791T (fr)
RS (1) RS65159B1 (fr)
RU (1) RU2019115672A (fr)
SI (1) SI3528791T1 (fr)
TW (1) TWI821163B (fr)
WO (1) WO2018077815A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115397422A (zh) 2019-11-29 2022-11-25 西皮欧生命科学有限公司 包含利匹韦林的组合物和其用于治疗肿瘤或癌症的用途
CN114392241B (zh) * 2022-01-10 2023-07-25 安徽贝克生物制药有限公司 一种利匹韦林片及其制备方法
GB202211231D0 (en) * 2022-08-02 2022-09-14 Glaxosmithkline Ip No 2 Ltd Novel formulation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0181966A1 (fr) * 1984-11-13 1986-05-28 Gist-Brocades N.V. Comprimés dispersibles enrobés par compression
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
PL208533B1 (pl) 2002-08-09 2011-05-31 Janssen Pharmaceutica Nv Sposób otrzymywania 4-[[4-[[4-(2-cyjanoetenylo)-2,6-dimetylofenylo]amino]-2-pirymidynylo]amino]benzonitrylu oraz sposób otrzymywania związku pośredniego
KR101284361B1 (ko) 2004-09-02 2013-07-15 얀센 파마슈티카 엔.브이. 4-((4-((4-(2-시아노에텐일)-2,6-디메틸페닐)아미노-2-피리미딘일)아미노)벤조니트릴의 하이드로클로라이드
ES2371442T7 (es) * 2004-09-02 2022-05-12 Janssen Pharmaceutica Nv Sal de 4-[[4-[[4-(2-cianoetenil)-2,6-dimetilfenil]amino]-2-pirimidinil]amino]benzonitrilo
UA92469C2 (en) * 2004-09-02 2010-11-10 Янссен Фармацевтика Н.В. Fumarate of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl amino benzonitrile
US20090176813A1 (en) 2006-06-23 2009-07-09 Lieven Elvire Colette Baert Aqueous suspensions of tmc278
WO2015120014A1 (fr) * 2014-02-05 2015-08-13 Merck Sharp & Dohme Corp. Nouveaux systèmes de désintégration de formes dosifiées pharmaceutiques
WO2015136294A1 (fr) * 2014-03-13 2015-09-17 Cipla Limited Composition pharmaceutique comprenant de la rilpivirine
AU2015258836B2 (en) * 2014-05-16 2020-07-16 Vivus, Inc. Orally disintegrating dosage form for administration of avanafil, and associated methods of manufacture and use

Also Published As

Publication number Publication date
MX2019004767A (es) 2019-07-01
PT3528791T (pt) 2024-02-19
ES2970870T3 (es) 2024-05-31
RU2019115672A3 (fr) 2021-01-21
SI3528791T1 (sl) 2024-04-30
WO2018077815A1 (fr) 2018-05-03
BR112019007564A2 (pt) 2019-07-02
PL3528791T3 (pl) 2024-04-02
CA3039562A1 (fr) 2018-05-03
EP3528791A1 (fr) 2019-08-28
US11065198B2 (en) 2021-07-20
DK3528791T3 (da) 2024-01-29
JP2023011659A (ja) 2023-01-24
TWI821163B (zh) 2023-11-11
EP4248947A2 (fr) 2023-09-27
RS65159B1 (sr) 2024-02-29
HRP20240118T1 (hr) 2024-04-12
EP4248947A3 (fr) 2023-11-22
US20220008333A1 (en) 2022-01-13
CN110191704A (zh) 2019-08-30
KR20190073450A (ko) 2019-06-26
HUE064823T2 (hu) 2024-04-28
TW201828927A (zh) 2018-08-16
JP2020500168A (ja) 2020-01-09
RU2019115672A (ru) 2020-11-24
MA46563B1 (fr) 2024-01-31
LT3528791T (lt) 2024-05-27
KR20240011873A (ko) 2024-01-26
JP7197474B2 (ja) 2022-12-27
US20200069579A1 (en) 2020-03-05
EP3528791B1 (fr) 2023-12-06
FI3528791T3 (fi) 2024-01-30

Similar Documents

Publication Publication Date Title
MA46458A (fr) Compositions debacillus thuringiensis
DK3361870T3 (da) Fungicidsammensætninger
DK3697376T3 (da) Sammensætning
DK3215173T3 (da) Glycopeptidsammensætninger
DK3416996T3 (da) Hærdelig sammensætning
DK3334726T3 (da) Plinabulinsammensætninger
MA41411A (fr) Compositions dispersibles
DK3528902T3 (da) Ringegelsammensætning
DK3451829T3 (da) Antimikrobielle sammensætninger
DK3215127T3 (da) Sammensætninger omfattende cyclosporin
DK3316857T3 (da) Multifasiske sammensætninger
DK3393254T3 (da) Sammensætning
MA46563A (fr) Compositions dispersibles
DK3200827T3 (da) Sammensætninger
DK3609464T3 (da) Xanthohumolbaserede sammensætninger
DK3554474T3 (da) Micafungin-sammensætninger
DK3416502T3 (da) Glykæmisk-reducerende sammensætning
DK3337322T3 (da) Fungicidsammensætninger
DK3317458T3 (da) Mineralsammensætninger
BR112017016240A2 (pt) composição
ES1209313Y (es) Composicion liofilizada
TR201503831A2 (tr) Antimipertansif kombinasyon formülasyonları
DK3393503T3 (da) Sammensætninger
DK3393238T3 (da) Dispergeringssammensætning
DK3322295T3 (da) Sammensætning